www.eclobeauty.com

Building Europe's
clean beauty supplement leader.

An established platform, 16K+ customers, 100 retail stores. H2 2026 launch of the highest-LTV category in beauty, led by a team that has already scaled.

ECLO BEAUTY — APRIL 2026 — CONFIDENTIAL

01 — THE TEAM
Marine Archer
CEO
Former CMO Nutripure (1M€→100M€, +90%/yr, PAI Partners exit 2024). 15 years in skincare and beauty.
ESSEC. Marketing Director NAOS/Bioderma. International Product Manager Pierre Fabre (Klorane). International marketing LATAM & Middle East.
Julien Callede
CO-FOUNDER
Co-founder of Made.com (0→£450M revenue, IPO 2021). COO for 7 years — operations, supply chain, European expansion.
HEC Paris. Board Decathlon Performance Sports. First shareholder and non-exec Healf.com, NextMomentum. Pre-seed investor.
02 — THE SUPPLEMENT OPPORTUNITY

Beauty supplements,
the new well-ageing imperative.

3B€
French supplement market 2025
+9% total +25% online
61%
French adults take supplements
+102%
Collagen growth in pharmacy — the category is exploding
We have entered a new era of aging and self-care. The glow-up comes from supporting the systems that keep the body vibrant, and alive.
Longevity starts from within. After 40, the body needs cellular support. This is the positioning Eclo 2.0 was built for.
03 — WHY ECLO

The only platform in France that
checks all 4 boxes to build the leader.

1. A CREDIBLE BRAND
B Corp certified, Cosmos Organic, 100% natural, zero plastic. 4.81/5 across 2,308 reviews. 150+ press features (ELLE, Vogue, Marie Claire, Le Monde, L'Obs).
Healf.com backer since inception — strategic validation from a leading wellness DTC player.
2. A CAPTIVE BASE · 16K+ CUSTOMERS
16,500+ engaged DTC customers. 72% already buy supplements elsewhere — conversion market, not acquisition. Zero incremental CAC to launch.
312K€ DTC year 1 revenue without acquiring a single new customer.
3. A DISTRIBUTION · 100 RETAIL STORES
100+ retail partners in France. Inbound B2B requests. 74% B2B margin. Launch channel with no additional retail cost.
Supplements = new category on the existing distribution base.
4. A TEAM THAT HAS ALREADY SCALED
Marine Archer (CEO): former CMO Nutripure, 1M€→100M€ (+90%/yr), PAI Partners exit 2024. Julien Callede: co-founder Made.com (£450M, IPO 2021).
The clean beauty supplement DNVB playbook, executed by operators who've done it.
No other French brand combines these 4 assets for the clean beauty supplement category.
04 — ECLO TODAY

A brand already built,
ready to scale.

16,500+
DTC customers
Captive, activable base
~100
Retail stores
Inbound B2B requests
4.81/5
Product rating
86% at 5 stars · 2,308 reviews
150+
Press features
ELLE, Vogue, Marie Claire
ELLE Vogue Marie Claire Le Monde L'Obs Biba
B Corp certified · Cosmos Organic · 100% natural · Zero plastic
05 — IN NUMBERS

~50K€/month turnover. 51% recurring.

Q1 23 Q1 24 Q1 25 Q1 26 8K€ 80K€
Quarterly recurring revenue · +934% in 3 years · from 15% to 51%
RECURRING REVENUE
27K€/mo
● ~10K€ BtC
● 15€–20K B2B
74%
B2B margin
3.24×
Ad ROI · spend -35%
STOCK VALUE
250K€
At cost — worth 1M€+ retail. Covers 6+ months.
CASH POSITION
Controlled
Reduced burn. Fixed costs <20K€/mo. Lean team (4).
NEXT LAUNCHES
May 26 · Regenerating Hand Balm
June 26 · Eye Patches
July 26 · Supplements (5 SKUs)
06 — PRODUCT LAUNCHES

100% success rate on recent product launches.

A successful repositioning towards clean skincare and a refocus of makeup towards higher-repeat, higher-margin products.

Soin Concentré
Launched Sept 2025 · Skincare
BATCH COST
30K€
REVENUE
47.5K€
Paid back in 4.5 months
1.58× return on investment
1,232 unique buyers
Run-rate: 5.2K€/mo HT
Sérum Lèvres
Launched Dec 2025 · Skincare
BATCH COST
20K€
REVENUE
22.5K€
Paid back in 4 months
885 unique buyers
1.13× return on investment
Run-rate: 5.0K€/mo HT
Crayons 3-en-1
Launched Feb 2026 · Colour + Care
BATCH COST
27K€
REVENUE
34.4K€
1.27× ROI · Fastest payback
20× markup · 70% of revenue B2B
#1 B2B product by revenue
Run-rate: 7.3K€/mo HT ↑
77K€ invested → 104.4K€ returned · 1.36× overall ROI · Run-rate 17.5K€/month · All launches profitable
07 — B2B GROSS MARGIN

+14.5 points of B2B gross margin in 6 months

From 53% (Q4 2025) to 67.5% (Mar 2026) — a record — driven by 3-in-1 pencil launch, new B2B bestsellers at 20× markup and low cash intensity.

34%
Q1 25
60%
Q2 25
44%
Q3 25
53%
Q4 25
66%
Q1 26
67.5%
Mar 26
What drove it
3-in-1 pencils at 20× markup — new B2B bestsellers with low cash intensity. Single product responsible for +12pts margin gain in Q1 2026.
Avec les compléments
Target supplement margin: 75-80% B2B. Launch would push blended margin toward >70% across the entire B2B catalogue.
08 — PRODUCT MIX TRANSFORMATION

18 months of transformation.
From V0.1 makeup to a high-recurrence model.

SEPTEMBER 2024
Before mascara launch
Makeup V0.1 73%
15%
● Makeup V0.1 73% ● Mascara 5% ● Skincare 15% ● Pencils 7%
Classic makeup = 78% of revenue
→
MARCH 2026
18 months later
V0.1 22%
Masc. 18%
Skincare 31%
Pencils 28%
● Makeup V0.1 22% ↓51pts ● Mascara 18% ↑13pts ● Skincare 31% ↑16pts ● Pencils 28% ↑21pts
Skincare + Pencils = 59% of revenue (was 22%)
MAKEUP V0.1
73% → 22%
Progressive phase-out
MASCARA + SKINCARE
20% → 49%
Strong repeat · 1–3×/yr
PENCILS
7% → 28%
20× markup · #1 B2B
NEXT 2 LAUNCHES — ACCELERATING THE TRANSITION
MAY 2026 TACTICAL LAUNCH
Regenerating Hand Balm
Quick win · Strong repeat (2×/yr) · Low batch cost · Tests the regenerative positioning before supplements.
JUNE / JULY 2026 STRATEGIC LAUNCH
Eye Patches
Strong repeat (2–3×/yr) · High Instagram/UGC potential · Bridge between skincare and supplements · Builds the repeat habit.
ECLO 2.0

Starting July 2026.

09 — THE MODEL & EXITS

A model with very high recurrence.
The big players have noticed.

WHY SUPPLEMENTS
Purchase frequency4–12×/year
Subscription rateup to 80–90%
DTC gross margin75–85%
CAC payback1–2 months
Customer LTV (3Y)800€–1,500+
RECENT EXITS
Nutrafol
Unilever 2022 · Revenue doubled post-acq.
$800M
Vital Proteins
Nestlé 2021 · Collagen · ~$250M rev.
$500M+
Nutripure 🇫🇷
PAI Partners 2024 · 1M€→100M€ · +90%/yr
majority
Europe is 5 years behind the US. Pharma brands dominate but lack beauty credibility. DTC beauty brands haven't leapt. Nobody has done it for beauty yet.
10 — CUSTOMER VALIDATION

Our customers already buy supplements.

We surveyed our customers. The market is already inside our base.

72%
Already buy supplements
From other brands. Capturing existing spend.
90%
Buy for clean ingredients
Same purchase driver. No repositioning.
74%
Indications covered
Looking for one or more indications covered by our supplement range.
74%
Trust ingredient science
Trust transfer already done.
51%
Revenue is already recurring
+934% in 3 years. Repeat is already the engine.
10K+
Addressable DTC customers
Captive base. Zero incremental CAC to launch.
11 — OUR PRODUCT STRATEGY

Innovation. Regeneration. Rituals.

01 — Classic brands repair skin. Eclo regenerates the terrain.

Cellular energy, inflammatory balance, hormonal and nervous terrain. No French brand has taken this territory.

02 — Complete formulas, built as systems.

8 months of formulation. Patented actives — ExceptionHYAL®star, Reggenerate®, SkinAx2™, Kaneka CoQ10, Ceramosides® Seppic, Albion®. Formulas designed as protocols.

03 — Innovative, non-animal, clinically superior sources.

Eggshell membrane collagen — vegetarian, biosourced, upcycled. 100% algae Omega 3 — no fish, no odor, optimized DHA/EPA ratio (500mg DHA / 100mg EPA). Natural and performance are no longer opposed.

04 — Designed to be taken. Really.

Two capsules per day. No taste. No odor. Adherence is problem #1 — we built it in from the start. A product taken daily is worth infinitely more than one that's forgotten.
12 — THE PRODUCT SYSTEM

Not just a lineup of products.
Real protocols and loyalty programs.

2 HERO PRODUCTS
HydraGlow — 42€
Hydration · Skin barrier · Glow — 25–40 ans
Fermeté & Well-Ageing — 45€
Anti-aging · Firmness · Cellular energy — 40+
3 MONO-INGREDIENTS & UNIVERSAL BASE
Hyalu Boost — 25€
Entry-level · Essential hydration
Complexe Collagène — 25€
Entry-level · Essential firmness
Omega Glow — 28€
Universal base · Inflammation, energy, mood. In every protocol.
THE 6 PROTOCOLS
01 — Découverte Hydra
Hyalu Boost + Omega Glow — 25–35 yrs — 53€/mo
02 — Découverte Anti-âge
Complexe Collagène + Omega Glow — 40+ — 53€/mo
03 — Essentiel Hydra
HydraGlow + Omega Glow — 25–40 yrs — 70€/mo
04 — Transition
HydraGlow + Complexe Collagène + Omega Glow — 38–45 yrs — 95€/mo
05 — Intensif Anti-âge
Fermeté & Well-Ageing + Omega Glow — 40+ — 73€/mo
06 — Régénératif Complet
HydraGlow + Fermeté + Omega Glow — 40+ — 115€/mo
5 produits · 6 protocoles · 115€/mo max
13 — PROTOCOL ECONOMICS

The economics of protocols.
The power of recurrence.

75%
Gross margin — HydraGlow
42€ TTC
78%
Gross margin — Fermeté & Well-Ageing
45€ TTC
79–82%
Gross margin — Mono-ingredients & Omega Glow
MONTHLY BASKET & LTV PER PROTOCOL (3-MONTH CURE)
PROTOCOL
TARGET
BASKET/MO
LTV 3 MONTHS
01 — Découverte Hydra
25–35 yrs
53€
159€
02 — Découverte Anti-âge
40+
53€
159€
03 — Essentiel Hydra
25–40 yrs
70€
210€
04 — Transition
38–45 yrs
95€
285€
05 — Intensif Anti-âge
40+
73€
219€
06 — Régénératif Complet
40+
115€/mo
345€ / 3 mois
Supplement repeat: 6×+ per year per SKU. Highest LTV, highest margin in the Eclo catalogue.
14 — ROADMAP 2026

A 2026 launch roadmap in 3 waves.
Each wave builds on the previous.

JULY 2026

Heroes + Mono-ingredients

HydraGlow · Fermeté · Hyalu Boost · Complexe Collagène

4 protocols. First sales on existing customer base.

SEPTEMBER 2026

Universal base + Full protocols

Omega Glow added. All 6 protocols live.

100-store retail activation. 3-month subscription cures.

NOVEMBER 2026

New skincare segments

Inflammation Fighter · Clear Skin+ · AOX Radiance+

8 products total. Repeat maximized.

15 — SUPERCHARGING REPEAT PURCHASES

A new engine enabling rapid acquisition scaling.

Today, on skincare + makeup, Eclo acquires a customer and waits 6–12 months before a potential reorder. Supplements completely invert this dynamic.

TODAY · SKINCARE
6–12 mo
Before 2nd purchase
Long payback = limited spend
WITH SUPPLEMENTS
~60 days
CAC payback on 1st order
Additional profit within 60 days
YEAR 1 ON PROTOCOL
6–12 orders
636€–1,380 revenue
75–82% gross margin
Skincare: Spend 25€ to acquire → wait 6–12 months → maybe 57€ back. Hard to scale.
Supplements: Spend 25€ → 70€ month 1, 70€ month 2, 70€ month 3. CAC recovered on 1st order.
Full protocol: 115€/mo × 12 = 1,380€/year at 77% margin. LTV:CAC of 30:1+.
15b — NET MARGIN BY MODEL

What each customer actually generates,
after all costs.

25€ CAC (order 1 only). 7€ logistics/order. COGS 22–35% depending on product.

YEAR 1
Eclo 0.1 · Makeup+1€
Eclo 0.2 · + Skincare+15€
Eclo 0.3 · + Supplements+79€
Includes 25€ CAC on 1st order
YEAR 2 CUMULATIVE
Eclo 0.1+1€
Eclo 0.2+20€
Eclo 0.3+154€
Zero CAC in year 2 · Pure margin
YEAR 3 CUMULATIVE
Eclo 0.1+2€
Eclo 0.2+24€
Eclo 0.3+229€
115× more net margin than makeup alone
Net margin = Revenue − COGS − logistics (7€/order) − CAC (25€, order 1 only, year 1 only). Eclo 0.3: Y2/Y3 = 4 orders × 105€, zero CAC.
16 — PROJECTIONS

Eclo 2026–2027–2028

2026
800K€
Net revenue HT
● LFL 66% ● Supplements 30%
Gross margin
572K€ 71.6%
EBITDA
~0€ breakeven
2027
2.1M€
Net revenue HT · ×2.7
● LFL 28% ● Supplements 70%
Gross margin
1.56M€ 73.4%
EBITDA
272K€ 12.8%
2028
5M€+
Net revenue HT · ×2.5
● Supplements >85%
Gross margin
3.75€–4.5M ~75%
EBITDA
0.75€–1.2M 15–20%
Internal projections. 2028 based on acquisition scaling + retail distribution + supplement repeat. EBITDA 2028 = contribution margin after all operating costs.
17 — THE PLAN

300K€ to accelerate.
Cash flow positive from H2 2026.

The current cash position already takes us to break-even 2026 with the supplements launch. These 300K€ are pure fuel to accelerate growth and finance inventory rotation.

USE OF FUNDS · 300K€
Acquisition & content 180K€ · 60%
Marketing fuel — paid social · influencers · UGC · supplement SEO
Supplement inventory rotation 90K€ · 30%
Financing batches 2 & 3 alongside the sales ramp-up
Contingency & working capital 30K€ · 10%
Buffer for seasonality and working capital requirements
CURRENT STRUCTURE
Cash sufficient for first supplement batch and operations. Fixed costs <20K€/month. Lean team of 4.
MILESTONES
H2 2026
Range launch · 2,100 customers converted · 800K€ total 2026 revenue · operational break-even
2027
2.1M€ revenue · EBITDA +272K€ (12.8%) · cash generating
2028
5M€+ revenue · EBITDA 0.75–1.2M€ · exit window
THANK YOU

Let's build Europe's
clean beauty
supplement leader together.

hello@eclobeauty.com www.eclobeauty.com
B Corp
Certified B Corp · Cosmos Organic
100% Natural · Zero Plastic

ECLO BEAUTY — APRIL 2026 — CONFIDENTIAL

APPENDIX — DETAILED P&L

Quarterly P&L 2026–2028.

€ HT Q1 26 Q2 26 Q3 26 Q4 26 2026 2027 2028 (E)
Net revenue 141K 127K 229K 302K 799K 2.13M 5M+
Of which BtC 83K 62K 152K 183K 480K 1.69M ~4M
Of which B2B 58K 65K 77K 119K 319K 436K ~1M
Gross margin 100K 89K 163K 220K 572K 1.56M ~3.75M
% margin 71% 70% 71% 73% 72% 73% ~75%
Operating costs -136K -114K -149K -170K -569K -1.29M ~-2.75M
Marketing -30K -17K -43K -51K -141K -440K -1M
Logistics -23K -20K -36K -48K -128K -330K -800K
Team/other -60K -60K -60K -60K -240K -426K -600K
EBITDA -37K -25K +14K +50K +2K +272K +0.75–1.2M
% EBITDA -26% -20% +6% +17% ~0% +12.8% 15–20%
Operational break-even reached Q3 2026 (supplement launch). 2027 EBITDA = 272K€ (12.8%). 2028 growth driven by acquisition scaling + retail + supplement repeat.
APPENDIX — UNIT ECONOMICS SENSITIVITY

The model holds in pessimistic scenarios.

3-year LTV per average Eclo 0.3 customer (with supplements). Sensitized variables: CAC, repeat rate, frequency.

SCENARIO CAC % REPEAT FREQ./YR 3Y LTV 3Y NET MARGIN LTV/CAC
Pessimistic 40€ 20% 2×/yr 196€ +105€ 4.9×
Conservative 35€ 22% 3×/yr 272€ +177€ 7.8×
Base (plan) 25€ 25% 3×/yr Y1, 4× Y2+ 359€ +229€ 14.4×
Optimistic 20€ 35% 4×/yr 497€ +342€ 24.9×
Nutrafol benchmark 30€ 55%+ 6×/yr 800€–1,500 +600€+ 25–50×
EVEN IN PESSIMISTIC
+105€ net margin per customer. 4.9× LTV/CAC. Model remains profitable.
BASE SCENARIO
+229€/customer over 3 years. 14× LTV/CAC. Numbers from internal benchmarks + Nutripure.
UPSIDE
If we approach Nutrafol (55% retention, 6×/yr), LTV/CAC exceeds 25×.
Net margin = Revenue − COGS (22%) − logistics (7€/order) − CAC (order 1 only). All scenarios assume 70€ initial basket and 105€ repeat basket.
APPENDIX — COMPETITION & EXITS

Clear comparables in a consolidating category.

BRAND CATEGORY COUNTRY REVENUE MARGIN % RECURRING EXIT REV. MULTIPLE
Nutrafol Hair supplements 🇺🇸 ~$200M ~80% 80%+ $800M ~4×
Vital Proteins Collagen 🇺🇸 ~$250M ~75% 70%+ $500M+ ~2×
OLLY Nutrition Wellness gummies 🇺🇸 ~$100M ~70% — undisclosed n/a
Nutripure Sport/health supplements 🇫🇷 70–100M€ ~65% 60%+ PAI Partners ~3–4×
HUM Nutrition Beauty supplements 🇺🇸 ~$80M ~70% 50%+ Sephora, Ulta private
Eclo (2028 plan) Clean beauty supplements 🇫🇷 5M€+ 75%+ 60%+ exit window 3–5× target
UNIQUE POSITIONING
Only French brand combining clean beauty + supplements + DTC + retail.
MARKET VISIBILITY
Active consolidation. 3 major US exits in 4 years. PAI Partners enters France.
TARGET MULTIPLE
3–5× revenue at exit is conservative vs Nutrafol (~4×) and Nutripure (~3–4×).
APPENDIX — TAM / SAM / SOM

A 3B€ market in France.
An accessible 300M€ share.

TAM · FRENCH SUPPLEMENTS MARKET
Synadiet 2025 · +5.7% YoY · doubled in 10 years
3B€
↓ Beauty & well-ageing focus
SAM · BEAUTY / WELL-AGEING SUPPLEMENTS
~25% of supplement market · Collagen +102% in pharmacy
750M€
↓ Clean / natural / DTC
SOM · ACCESSIBLE CLEAN BEAUTY SUPPLEMENTS
~40% of SAM (80% want natural, 53% want organic)
300M€
↓ Eclo 2028 ambition
ECLO 2028 TARGET
~1.7% of SOM
5M€+
61%
Adults take
supplements
77%
Take multiple
times/yr · +12pt vs 2021
+25%
Online growth
in supplements
+40%
Gummies growth
in France
Sources: Synadiet 2025, IQVIA pharmacy 2024, Xerfi supplements 2024. Europe (Germany, UK, Italy) represents ~3× France = ~9B€ European TAM.